CN113144016A - Medicine for treating rhinitis and preparation process thereof - Google Patents

Medicine for treating rhinitis and preparation process thereof Download PDF

Info

Publication number
CN113144016A
CN113144016A CN202110585662.XA CN202110585662A CN113144016A CN 113144016 A CN113144016 A CN 113144016A CN 202110585662 A CN202110585662 A CN 202110585662A CN 113144016 A CN113144016 A CN 113144016A
Authority
CN
China
Prior art keywords
parts
medicine
rhinitis
asarum
radix angelicae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110585662.XA
Other languages
Chinese (zh)
Inventor
周国亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110585662.XA priority Critical patent/CN113144016A/en
Publication of CN113144016A publication Critical patent/CN113144016A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268Asarum (wild ginger)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the important technical field, in particular to a medicine for treating rhinitis and a preparation process thereof, the rhinitis medicine provided by the invention is prepared into powder by Chinese herbal medicine components, different medicines are pretreated and then ground into particles for standby, the particles are stirred according to the preparation proportion to obtain a finished product, the finished product is treated in a nasal cavity by a spray can, the medicine is taken for 1-2 times per week according to symptoms, the medicine frequency is greatly reduced, the medicine is prepared by pure Chinese herbal medicines, the treatment cost of a patient is reduced under the condition of not influencing the medicine effect, the medicine is prepared by Chinese herbal medicines, no side effect is produced when the medicine is used, and the medicine can be used safely.

Description

Medicine for treating rhinitis and preparation process thereof
Technical Field
The invention relates to the important technical field, in particular to a medicine for treating rhinitis and a preparation process thereof.
Background
Rhinitis, an inflammatory disease of the nasal cavity, is inflammation of the mucous membrane of the nasal cavity caused by viruses, bacteria, allergens, various physicochemical factors and certain systemic diseases. The main pathological changes of rhinitis are congestion, swelling, exudation, hyperplasia, atrophy or necrosis of the nasal mucosa. The rhinitis is complicated and diversified in constitutional reasons, generally divided into hereditary, viral infection, allergic infection and the like, slight rhinitis has little influence on work and life of people, but serious rhinitis can cause severe consequences such as migraine, dizziness and complications and the like, the rhinitis is not easy to eradicate in treatment in slight or serious conditions, continuous medication is needed, and great inconvenience is brought to life of people.
At present, most of rhinitis medicines in the market are prepared into rhinitis tablets by a Chinese-western combined pharmaceutical method, the rhinitis tablets are taken orally for treatment, the number of the rhinitis tablets is limited during use, the purpose of eradicating the rhinitis cannot be achieved, patients need to take the rhinitis tablets for a long time to relieve discomfort of the patients, the rhinitis tablets can generate resistance to the medicines after being taken for a long time, and the efficacy of the rhinitis tablets is gradually reduced.
Disclosure of Invention
The invention aims to overcome the defects that the existing medicine can not eradicate rhinitis and needs to be taken frequently for a long time, and provides a medicine for treating the rhinitis with low use frequency and small irritation and a preparation process thereof.
The invention is realized by the following technical scheme: the medicine for treating rhinitis comprises, by weight, 6-15 parts of magnolia flower, 5-15 parts of asarum, 10-25 parts of pedicellus melo, 1-6 parts of ligusticum wallichii, 0.5-3 parts of borneol, 3-15 parts of centipeda minima, 2-9 parts of rhizoma coptidis, 5-16 parts of mint, 2-8 parts of radix angelicae, 2-8 parts of loofah flesh and 0.5-5 parts of artificial musk.
Furthermore, the medicine for treating rhinitis comprises the following raw materials, by weight, 8-12 parts of magnolia flower, 6-10 parts of asarum, 12-20 parts of muskmelon pedicel, 2-5 parts of ligusticum wallichii, 1-3 parts of borneol, 5-10 parts of centipeda minima, 4-8 parts of coptis chinensis, 8-12 parts of mint, 3-6 parts of radix angelicae, 3-6 parts of vegetable sponge and 1-3 parts of artificial musk.
Furthermore, the medicine for treating rhinitis comprises the following raw materials, by weight, 9 parts of magnolia flower, 9 parts of asarum, 15 parts of muskmelon pedicel, 3 parts of ligusticum wallichii, 3 parts of borneol, 9 parts of centipeda minima, 5 parts of coptis chinensis, 9 parts of mint, 4 parts of radix angelicae, 5 parts of vegetable sponge and 2 parts of artificial musk.
Further, the preparation process of the rhinitis medicine comprises the following steps: step 1: preparing medicinal materials, namely cleaning flos magnoliae, asarum, muskmelon pedicel, ligusticum wallichii, borneol, centipeda minima, goldthread root, mint, radix angelicae, loofah sponge and artificial musk, removing dirt and drying in the shade;
step 2: soaking rhizoma Ligustici Chuanxiong in rice wine for pretreatment, the pretreatment method comprises: cleaning rhizoma Ligustici Chuanxiong, drying in the shade, sealing in rice wine, soaking in the shade at normal temperature for 1-5 days, and exciting the property of rhizoma Ligustici Chuanxiong with rice wine;
and step 3: parching flos Magnoliae in casserole at 30-50 deg.C for 30-60 min until the surface of flos Magnoliae turns yellow, grinding, and sieving with 200 mesh sieve;
and 4, step 4: calcining radix Angelicae Dahuricae and Coptidis rhizoma, grinding, and sieving with 200 mesh sieve;
and 5: sterilizing herba asari, pedicellus melo, rhizoma Ligustici Chuanxiong, Borneolum Syntheticum, herba Centipedae, herba Menthae, fructus Luffae, and artificial Moschus in a steamer for 3-5 hr, parching the different herbs separately, grinding, and sieving with 200 mesh sieve;
step 6: and (3) proportioning the standby materials obtained in the steps 1-5, uniformly stirring and preparing into powder.
The using method comprises the following steps: the powder taking device comprises a spraying pot, wherein the spraying pot is used for taking 0.05-0.15g of powder each time, the spraying pot is stretched into a nasal cavity for spraying, the powdery medicinal powder is sprayed into the nasal cavity, the spraying pot comprises an air bag, a medicine taking short pipe is arranged at an air outlet of the air bag, the powder is sprayed into the nasal cavity through air bag compression after the medicine is filled by the medicine taking short pipe, the medicine is sprayed to a focus of a patient, goose does not eat and magnolia flower is warm in nature and plays a role in dispelling wind and cold, corydalis tuber, mint and coptis borneol are cold in nature and cool in nature, the effects of dispelling wind and heat and clearing and detoxifying are played, loofah and angelica dahurica play a role in diminishing inflammation and easing pain, the patient takes 0.1g +/-0.05 g each time every time, the dosage is properly adjusted according to the disease duration of the patient and the tolerance to the medicine, and spicy food, tobacco, wine and other strong irritant articles are fast during the medicine taking period.
The invention has the beneficial effects that: the Chinese herbal medicine powder is prepared by Chinese herbal medicine components, different medicines are pretreated and then ground into particles for standby, the particles are stirred according to a preparation ratio to obtain a finished product, the medicine is used in a nasal cavity through a spray can for 1-2 times per week according to symptoms, the medicine frequency is greatly reduced, the medicine is prepared by pure Chinese herbal medicines, the treatment cost of a patient is reduced under the condition that the medicine effect is not influenced, the Chinese herbal medicines are prepared, no side effect is caused during use, the medicine cannot be depended on, and the medicine can be used safely.
Detailed Description
Mint: it is pungent and cool, and has effects of removing toxic substance, inducing perspiration, dispelling pathogenic wind, and removing heat when entering lung and liver channels.
Centipeda minima: it is pungent and warm in flavor and enters lung and liver meridians. The efficacy is as follows: disperse wind-cold, sores, abscess and toxic swelling.
And (3) magnolia flower: pungent and warm in flavor, enter lung and stomach meridians. The efficacy is as follows: unblocking lung and inducing resuscitation, and dispelling wind-cold. The medicine is essential for treating headache, nasal obstruction, bad smell and frequent thick nasal discharge.
Asarum: also called asarum, asarum simsii, etc., belonging to the order of aristolochiales, aristolochiaceae, perennial herbs; the rootstock is upright or transverse, and has a plurality of fibrous roots; 2 leaves are usually in heart shape or egg shape, and the flower is purple black; the flower stalk is 2-100 px long; the flower envelope has a triangular, oval shape, approximately spherical shape, a diameter of about 37.5px, and a brownish yellow color. The flowering period is 4-5 months. Has the functions of expelling wind, dispelling cold, promoting diuresis, inducing resuscitation, etc. It is commonly used for wind-cold headache, nasosinusitis, toothache, phlegm-fluid cough, wind-damp arthralgia, etc. The asarum can not only externally disperse wind-cold, but also internally dispel yin-cold, and has better effects of relieving pain and cough;
ligusticum wallichii: the surface is gray brown or brown, rough and wrinkled, and has a plurality of parallel raised wheel nodes, a concave round-like stem mark at the top end, and a plurality of small nodular root marks on the lower side and the wheel nodes. Firm, hard to break, yellow-white or gray-yellow cross section, dispersed with yellow-brown oil chamber, forming a wavy lamellar ring. Fragrant smell, bitter and pungent taste, slightly numb tongue and slightly sweet.
Muskmelon pedicel: pungent, cold and bitter. It enters heart and spleen meridians. The functions are as follows: clearing away heat and toxic materials, and eliminating carbuncle and swelling, and can be used for treating sore throat, furuncle, sore pain, carbuncle, cellulitis, carbuncle on the back, nephritis, parotitis, and other pyogenic infections.
And (3) yellow lotus: it is bitter in taste and cold in nature and enters the large intestine meridian of heart, gallbladder, stomach. The efficacy is as follows: clearing heat and drying dampness, purging pathogenic fire and removing toxicity, mainly treating the symptoms of the dampness and heat, blood heat, conjunctival congestion, toothache, diabetes, carbuncle, swelling and sore, eczema and ear canal purulence.
Borneol: pungent and bitter in flavor, cool in nature, and entering heart and lung meridians. The efficacy is as follows: unblocking orifices, dispelling stagnated fire, removing nebula, improving eyesight, relieving swelling and alleviating pain. The main treatment is as follows: coma due to febrile disease, fright epilepsy, phlegm coma, qi block, deafness, aphtha, otitis media, carbuncle and swelling, hemorrhoid, etc.
Radix angelicae: white, warm in nature, pungent and slightly bitter in taste, has the effects of dispelling wind and eliminating dampness, dredging orifices and relieving pain, and reducing swelling and expelling pus, is widely used for treating diseases such as cold headache, eyebrow prism pain, nasal obstruction, nasosinusitis, toothache, leucorrhea, abscess and the like in clinic, and has better curative effect.
Vegetable sponge: also called luffa mesh, luffa shell, luffa vegetable sponge, luffa pulp, luffa thread, luffa tendon, luffa vegetable sponge, serrate club moss, is the vascular bundle in the mature fruit of the annual herb luffa belonging to the cucurbitaceae family or the withered fruit of luffa. The towel gourd is a common vegetable in summer and autumn in China, is produced in most provinces in China, is a cultivation product, and has good quality for Jiangsu and Zhejiang. The loofah sponge contains xylan, mannan, galactan and the like, the decoction has obvious effects of easing pain, calming and resisting inflammation, and clinical researches show that the loofah sponge has certain curative effects on treating acute mastitis, herpes zoster around eyes, thyroid adenoma and the like by oral administration and external application
Artificial musk: the artificial musk is a fragrant and warm medicine for inducing resuscitation, has the functions of inducing resuscitation and refreshing mind, promoting blood circulation and removing stasis, and inducing parturition and removing fetuses, and has the effects of invigorating heart and spleen channels. The function is as follows: 1. it has strong actions of inducing resuscitation and unblocking, so it is indicated for coma and convulsion due to invasion of warm disease heat into pericardium, and convulsions and phlegm syncope due to apoplexy. 2. It can move blood system and has the actions of promoting blood circulation and resolving hard mass, and relieving swelling and pain, and is often combined with toxicity-removing and blood-activating herbs, and used for sores and furuncles with internal or external application.
Example 1
Preparing raw materials: taking 6g of biond magnolia flower, 5g of asarum, 10g of muskmelon pedicel, 1g of ligusticum wallichii, 0.5g of borneol, 3g of centipeda minima, 2g of rhizoma coptidis, 5g of mint, 2g of angelica dahurica, 2g of luffa pulp and 0.5g of artificial musk;
cleaning rhizoma Ligustici Chuanxiong, drying in the shade, soaking in rice wine for 0.5-2 days, taking out, drying in the shade again, parching in casserole for 1-2 hr to remove water in the herbs, parching, grinding, and sieving with 200 mesh sieve; parching flos Magnoliae in marmite at 50 deg.C for 50 min, stopping parching after the villi on flos Magnoliae surface falls off and turns yellow, parching to dry, grinding, and sieving with 200 mesh sieve;
calcining radix Angelicae Dahuricae and Coptidis rhizoma, grinding, and sieving with 200 mesh sieve;
sterilizing herba asari, pedicellus melo, rhizoma Ligustici Chuanxiong, Borneolum Syntheticum, herba Centipedae, herba Menthae, fructus Luffae, and artificial Moschus in a steamer for 4 hr, parching the different herbs separately, grinding, and sieving with 200 mesh sieve;
uniformly stirring the prepared medicinal powder, adding the asarum, the muskmelon pedicel, the ligusticum wallichii, the borneol, the centipeda minima, the mint, the vegetable sponge and the artificial musk into a stirrer, uniformly stirring, adding the magnolia flower and the asarum, stirring again, finally adding the angelica dahurica and the coptis chinensis, stirring for 2-5 hours, and uniformly mixing the components to obtain a finished product.
Example 2
Preparing raw materials: taking 15g of biond magnolia flower, 15g of asarum, 25g of muskmelon pedicel, 6g of ligusticum wallichii, 3g of borneol, 15g of centipeda minima, 9g of rhizoma coptidis, 16g of mint, 8g of radix angelicae, 8g of luffa pulp and 5g of artificial musk;
cleaning rhizoma Ligustici Chuanxiong, drying in the shade, soaking in rice wine for 0.5-2 days, taking out, drying in the shade again, parching in casserole for 1-2 hr to remove water in the herbs, parching, grinding, and sieving with 200 mesh sieve; parching flos Magnoliae in marmite at 50 deg.C for 50 min, stopping parching after the villi on flos Magnoliae surface falls off and turns yellow, parching to dry, grinding, and sieving with 200 mesh sieve;
calcining radix Angelicae Dahuricae and Coptidis rhizoma, grinding, and sieving with 200 mesh sieve;
sterilizing herba asari, pedicellus melo, rhizoma Ligustici Chuanxiong, Borneolum Syntheticum, herba Centipedae, herba Menthae, fructus Luffae, and artificial Moschus in a steamer for 4 hr, parching the different herbs separately, grinding, and sieving with 200 mesh sieve;
uniformly stirring the prepared medicinal powder, adding the asarum, the muskmelon pedicel, the ligusticum wallichii, the borneol, the centipeda minima, the mint, the vegetable sponge and the artificial musk into a stirrer, uniformly stirring, adding the magnolia flower and the asarum, stirring again, finally adding the angelica dahurica and the coptis chinensis, stirring for 2-5 hours, and uniformly mixing the components to obtain a finished product.
Example 3
Preparing raw materials: taking 12g of biond magnolia flower, 10g of asarum, 18g of muskmelon pedicel, 3g of ligusticum wallichii, 2g of borneol, 8g of centipeda minima, 6g of goldthread root, 13g of mint, 5g of angelica dahurica, 5g of luffa pulp and 1g of artificial musk;
cleaning rhizoma Ligustici Chuanxiong, drying in the shade, soaking in rice wine for 0.5-2 days, taking out, drying in the shade again, parching in casserole for 1-2 hr to remove water in the herbs, parching, grinding, and sieving with 200 mesh sieve; parching flos Magnoliae in marmite at 50 deg.C for 50 min, stopping parching after the villi on flos Magnoliae surface falls off and turns yellow, parching to dry, grinding, and sieving with 200 mesh sieve;
calcining radix Angelicae Dahuricae and Coptidis rhizoma, grinding, and sieving with 200 mesh sieve;
sterilizing herba asari, pedicellus melo, rhizoma Ligustici Chuanxiong, Borneolum Syntheticum, herba Centipedae, herba Menthae, fructus Luffae, and artificial Moschus in a steamer for 4 hr, parching the different herbs separately, grinding, and sieving with 200 mesh sieve;
uniformly stirring the prepared medicinal powder, adding the asarum, the muskmelon pedicel, the ligusticum wallichii, the borneol, the centipeda minima, the mint, the vegetable sponge and the artificial musk into a stirrer, uniformly stirring, adding the magnolia flower and the asarum, stirring again, finally adding the angelica dahurica and the coptis chinensis, stirring for 2-5 hours, and uniformly mixing the components to obtain a finished product.
Typical cases are:
serial number Patient's health Sex Age (age) Time of illness Causes of disease Time of administration Whether the disease is healed or not Whether or not the disease recurs within 1 year
1 Jia somewhere For male 65 For 30 years Viral rhinitis 32 weeks Recovery method No recurrence
2 Lie somewhere For male 51 12 years old Viral rhinitis For 16 weeks Recovery method No recurrence
3 King of a certain For male 12 1 year Allergic rhinitis 8 weeks Is effective
4 Liu (Chinese character) Gong Woman 53 For 10 years Nasosinusitis 24 weeks Recovery method No recurrence
5 Lie somewhere Woman 30 For 3 years Nasosinusitis For 12 weeks Is effective
6 Liu (Chinese character) Gong Woman 43 5 years old Atrophic rhinitis For 16 weeks Recovery method No recurrence
7 Horse's horn For male 57 11 years old Nasal polyp For 16 weeks Recovery method No recurrence
8 Dong's somebody Woman 48 7 years old Nasosinusitis For 16 weeks Recovery method No recurrence
9 Yang Gong For male 58 11 years old Viral rhinitis For 36 weeks Is effective
10 Chen (a certain) For male 40 5 years old Nasal polyp For 12 weeks Recovery method No recurrence
As can be seen from the above table, the rhinitis medicine prepared by the invention is less influenced by the age, sex and illness time in treatment, and has no recurrence after recovery.
And (3) statistical data display:
serial number Time of illness Number of patients The powder of the invention is used for a long time Dosage and frequency Rate of recovery Whether or not the disease is relapsed
1 0-1 year 50 8 weeks 1 time/week 99% No recurrence
2 1-3 years old 500 10-20 weeks 1 time/week 99% No recurrence
3 3-8 years old 100 20-30 weeks 1 time/week 98% No recurrence
4 For more than 8 years 10 30-35 weeks 2 times/week 95% No recurrence
As can be seen from the above table, the rhinitis drug prepared by the present invention still has a high cure rate when treating a patient with chronic dermatitis, and the shorter the disease duration, the shorter the treatment duration and the higher the cure rate.
According to the data display results, the patient has high recovery rate when using the medicament provided by the invention, and has no relapse after recovery.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that modifications may be made to the embodiments or portions thereof without departing from the spirit and scope of the invention.

Claims (4)

1. A medicine for treating rhinitis is characterized in that: the composite material is characterized by comprising the following raw materials in parts by weight: 6-15 parts of biond magnolia flower, 5-15 parts of asarum, 10-25 parts of muskmelon pedicel, 1-6 parts of ligusticum wallichii, 0.5-3 parts of borneol, 3-15 parts of centipeda minima, 2-9 parts of coptis chinensis, 5-16 parts of mint, 2-8 parts of radix angelicae, 2-8 parts of loofah flesh and 0.5-5 parts of artificial musk.
2. A medicament for the treatment of rhinitis according to claim 1, wherein: 8-12 parts of biond magnolia flower, 6-10 parts of asarum, 12-20 parts of muskmelon pedicel, 2-5 parts of ligusticum wallichii, 1-3 parts of borneol, 5-10 parts of centipeda minima, 4-8 parts of coptis chinensis, 8-12 parts of mint, 3-6 parts of radix angelicae, 3-6 parts of loofah sponge and 1-3 parts of artificial musk.
3. A medicament for the treatment of rhinitis according to claim 1, wherein: 9 parts of biond magnolia flower, 9 parts of asarum, 15 parts of muskmelon pedicel, 3 parts of ligusticum wallichii, 3 parts of borneol, 9 parts of centipeda minima, 5 parts of goldthread root, 9 parts of mint, 4 parts of radix angelicae, 5 parts of luffa pulp and 2 parts of artificial musk.
4. A process for the preparation of a medicament as claimed in any one of claims 1 to 3 for the treatment of rhinitis, characterized in that: the preparation method comprises the following preparation steps:
step 1: preparing medicinal materials, namely cleaning flos magnoliae, asarum, muskmelon pedicel, ligusticum wallichii, borneol, centipeda minima, goldthread root, mint, radix angelicae, loofah sponge and artificial musk, removing dirt and drying in the shade;
step 2: soaking rhizoma Ligustici Chuanxiong in rice wine for pretreatment;
and step 3: parching flos Magnoliae in casserole at 30-50 deg.C for 30-60 min until the surface of flos Magnoliae turns yellow, grinding, and sieving with 200 mesh sieve;
and 4, step 4: calcining radix Angelicae Dahuricae and Coptidis rhizoma, grinding, and sieving with 200 mesh sieve;
and 5: sterilizing herba asari, pedicellus melo, rhizoma Ligustici Chuanxiong, Borneolum Syntheticum, herba Centipedae, herba Menthae, fructus Luffae, and artificial Moschus in a steamer for 3-5 hr, parching the different herbs separately, grinding, and sieving with 200 mesh sieve;
step 6: and (3) proportioning the standby materials obtained in the steps 1-5, uniformly stirring and preparing into powder.
CN202110585662.XA 2021-05-27 2021-05-27 Medicine for treating rhinitis and preparation process thereof Pending CN113144016A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110585662.XA CN113144016A (en) 2021-05-27 2021-05-27 Medicine for treating rhinitis and preparation process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110585662.XA CN113144016A (en) 2021-05-27 2021-05-27 Medicine for treating rhinitis and preparation process thereof

Publications (1)

Publication Number Publication Date
CN113144016A true CN113144016A (en) 2021-07-23

Family

ID=76877909

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110585662.XA Pending CN113144016A (en) 2021-05-27 2021-05-27 Medicine for treating rhinitis and preparation process thereof

Country Status (1)

Country Link
CN (1) CN113144016A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103830441A (en) * 2013-12-06 2014-06-04 济南新起点医药科技有限公司 Traditional Chinese medicine composition for treating rhinitis
CN105287772A (en) * 2015-11-03 2016-02-03 北京科炎堂生物科技有限公司 Traditional Chinese medicine antibacterial powder for treating rhinitis and preparation method thereof
CN106110135A (en) * 2016-07-28 2016-11-16 王连根 A kind of Chinese medicine for treating rhinitis and preparation method thereof
CN107412530A (en) * 2017-08-07 2017-12-01 李亚彬 A kind of ointment for treating rhinitis and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103830441A (en) * 2013-12-06 2014-06-04 济南新起点医药科技有限公司 Traditional Chinese medicine composition for treating rhinitis
CN105287772A (en) * 2015-11-03 2016-02-03 北京科炎堂生物科技有限公司 Traditional Chinese medicine antibacterial powder for treating rhinitis and preparation method thereof
CN106110135A (en) * 2016-07-28 2016-11-16 王连根 A kind of Chinese medicine for treating rhinitis and preparation method thereof
CN107412530A (en) * 2017-08-07 2017-12-01 李亚彬 A kind of ointment for treating rhinitis and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张茂兰等: "鹅不食草散治疗慢性鼻炎", 《中国民间疗法》 *
王璟等: "慢性鼻炎中医药治疗进展", 《中国民族民间医药》 *

Similar Documents

Publication Publication Date Title
CN100471509C (en) Medicine for treating tympanitis and otitis externa, and preparing method
CN106359720A (en) Health protection tea for clearing heat from throat and moistening lung and preparation method thereof
CN110652544A (en) Pharmaceutical composition for treating rhinitis and preparation method thereof
CN110652552A (en) Wound healing formula and preparation method
WO2023125798A1 (en) Traditional chinese medicine composition and preparation method and application thereof
CN116115689A (en) Seven-orifice rhinitis-relieving spray and preparation method thereof
CN1318052C (en) Medicine compositions for treating acne, and its prepn. method
CN113144016A (en) Medicine for treating rhinitis and preparation process thereof
CN114306478B (en) A Chinese medicinal composition for treating dermatoses
CN105106696A (en) Traditional Chinese medicinal composition for treating chronic prostatitis
CN110917271A (en) Spray for preventing and treating allergic asthma combined allergic rhinitis of children and teenagers
CN104645113A (en) Traditional Chinese medicine preparation for treating nasopharyngeal carcinoma and preparation method of traditional Chinese medicine preparation
CN115969930B (en) Pharmaceutical composition for chronic pharyngitis
CN104189489A (en) Medicament with effect of treating chronic eczema and preparation method thereof
CN113769046B (en) Traditional Chinese medicine composition for treating intestinal metaplasia, preparation method and application
CN116459314B (en) Aging-delaying spray
CN105709099A (en) Nose drop for relieving nasal polyp symptom and preparation method
CN106039075A (en) Traditional Chinese medicine composition and method for treating lung and stomach heat accumulated type chronic pharyngitis
CN105998979A (en) Traditional Chinese medicine composition for treating lung-and-kidney-yin-deficiency-type chronic pharyngitis and method
CN109223963A (en) A kind of Chinese medicine composition and preparation method thereof for treating pharyngitis
CN101129571A (en) Oral liquid of prunella spike
CN105250563A (en) Chinese herb preparation for treating pediatric intestinal parasites and preparing method thereof
CN109602864A (en) The happy liquid of Thief zone and preparation method thereof of nasopharyngeal mucosa is repaired in a kind of nutrition
CN115518113A (en) Oral medicine for treating hemorrhoids and preparation method thereof
CN114732846A (en) Application, use method and preparation method of rhinitis traditional Chinese medicine composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210723